DLEU1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.801000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.404640E-01
Normal-vs-Stage2
5.420800E-01
Normal-vs-Stage3
7.544000E-01
Normal-vs-Stage4
6.238800E-01
Stage1-vs-Stage2
1.038190E-01
Stage1-vs-Stage3
7.338000E-02
Stage1-vs-Stage4
1.428960E-01
Stage2-vs-Stage3
3.203200E-01
Stage2-vs-Stage4
8.499800E-01
Stage3-vs-Stage4
4.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.781000E-01
Normal-vs-AfricanAmerican
5.717200E-01
Normal-vs-Asian
4.539000E-01
Caucasian-vs-AfricanAmerican
7.866800E-01
Caucasian-vs-Asian
4.645000E-01
AfricanAmerican-vs-Asian
9.326000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.759400E-01
Normal-vs-Female
5.019600E-01
Male-vs-Female
9.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.264200E-01
Normal-vs-Age(41-60Yrs)
4.073600E-01
Normal-vs-Age(61-80Yrs)
5.506200E-01
Normal-vs-Age(81-100Yrs)
3.877000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.036800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.585600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.853200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.164600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.177600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.063200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.724800E-01
Normal-vs-Daily Drinker
5.823600E-01
Normal-vs-Weekly Drinker
9.518800E-01
Normal-vs-Occasional Drinker
3.731000E-01
Normal-vs-Social Drinker
3.243800E-01
Non Drinker-vs-Daily Drinker
8.922400E-01
Non Drinker-vs-Weekly Drinker
2.252600E-01
Non Drinker-vs-Occasional Drinker
3.446600E-01
Non Drinker-vs-Social Drinker
4.827800E-01
Daily Drinker-vs-Weekly Drinker
1.841370E-01
Daily Drinker-vs-Occasional Drinker
4.745000E-01
Daily Drinker-vs-Social Drinker
6.184800E-01
Weekly Drinker-vs-Occasional Drinker
5.088000E-02
Weekly Drinker-vs-Social Drinker
5.769700E-02
Occasional Drinker-vs-Social Drinker
8.125600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.501810E-01
Normal-vs-Grade 2
5.014000E-02
Normal-vs-Grade 3
7.351700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.376400E-01
Grade 1-vs-Grade 3
1.311570E-01
Grade 1-vs-Grade 4
1.501810E-01
Grade 2-vs-Grade 3
4.583400E-01
Grade 2-vs-Grade 4
5.014000E-02
Grade 3-vs-Grade 4
7.351700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.698800E-01
Normal-vs-NonDiabetic
4.392000E-01
Diabetic-vs-NonDiabetic
3.933700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.860800E-01
Normal-vs-NoPancreatitis
5.035800E-01
Pancreatitis-vs-NoPancreatitis
2.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.419600E-01
Normal-vs-N1
4.928000E-01
N0-vs-N1
2.281000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.046800E-01
Normal-vs-TP53-NonMutant
2.247200E-01
TP53-Mutant-vs-TP53-NonMutant
2.677000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
